New Alzheimer's drug aims to ease symptoms and help caregivers
Symptom relief
Recruiting now
This study tests the safety and tolerability of the drug Zunveyl in 150 adults aged 50 and older with mild to moderate Alzheimer's disease. Over 12 weeks, researchers will monitor side effects and whether the drug helps reduce neuropsychiatric symptoms like agitation or mood chan…
Phase: PHASE4 • Sponsor: Alpha Cognition, Inc • Aim: Symptom relief
Last updated Jun 27, 2026 13:04 UTC